Mohit Jain

475 total citations
25 papers, 309 citations indexed

About

Mohit Jain is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Mohit Jain has authored 25 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Genetics. Recurrent topics in Mohit Jain's work include Lysosomal Storage Disorders Research (10 papers), Glycogen Storage Diseases and Myoclonus (3 papers) and Spinal Dysraphism and Malformations (3 papers). Mohit Jain is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Glycogen Storage Diseases and Myoclonus (3 papers) and Spinal Dysraphism and Malformations (3 papers). Mohit Jain collaborates with scholars based in United States, United Kingdom and Germany. Mohit Jain's co-authors include Christian J. Hendriksz, Sema Kalkan Uçar, Mahmut Çöker, Christina Lampe, Christine Lavery, Andrew Olaye, Stuart Zarich, Frans J. Th. Wackers, Ben A. Lin and Regina Leadley and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Mohit Jain

24 papers receiving 300 citations

Peers

Mohit Jain

PHYSI

EPIDE

RHEUM

CCM

PMH

J. Michael Taylor United States

Barbara Martinelli Brazil

Eriko Yamaguchi Japan

Agnieszka Różdżyńska‐Świątkowska Poland

Qiuyue Tian China

Joy Buie United States

Sema Yılmaz Türkiye

Adeel Nasir United States

Eveline J. Langereis Netherlands

L. D. Jacobs Netherlands

J. Michael Taylor United States

Mohit Jain

118 ×0.8

PHYSI

119 ×1.7

EPIDE

44 ×0.7

RHEUM

24 ×0.5

CCM

28 ×0.5

PMH

Citations per year, relative to Mohit Jain Mohit Jain (= 1×) peers J. Michael Taylor

Countries citing papers authored by Mohit Jain

Since Specialization

Citations

This map shows the geographic impact of Mohit Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohit Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohit Jain more than expected).

Fields of papers citing papers by Mohit Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohit Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohit Jain. The network helps show where Mohit Jain may publish in the future.

Co-authorship network of co-authors of Mohit Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Mohit Jain. A scholar is included among the top collaborators of Mohit Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohit Jain. Mohit Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allevato, Michael M., Keiichi Koshizuka, Daniela Nachmanson, et al.. (2024). A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death. Cancer Letters. 598. 217089–217089. 8 indexed citations

Specchio, Nicola, Paul Gissen, Emily de los Reyes, et al.. (2024). Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data. PLoS ONE. 19(5). e0302382–e0302382. 2 indexed citations

Boysen, Meindert, Kenneth Bond, Rick A. Vreman, et al.. (2024). An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report. International Journal of Technology Assessment in Health Care. 40(1). e45–e45. 4 indexed citations

Gissen, Paul, Nicola Specchio, Andrew Olaye, et al.. (2021). Investigating health-related quality of life in rare diseases: a case study in utility value determination for patients with CLN2 disease (neuronal ceroid lipofuscinosis type 2). Orphanet Journal of Rare Diseases. 16(1). 217–217. 10 indexed citations

Kenny, Thomas, et al.. (2021). Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement. Orphanet Journal of Rare Diseases. 16(1). 394–394. 6 indexed citations

Trefz, Friedrich K., Ania C. Muntau, Christian Jacob, et al.. (2021). Health economic burden of patients with phenylketonuria (PKU) – A retrospective study of German health insurance claims data. Molecular Genetics and Metabolism Reports. 27. 100764–100764. 10 indexed citations

Le, Viet T., Stacey Knight, Kirk U. Knowlton, et al.. (2021). HIGHER DOCOSAHEXAENOIC ACID LEVELS LOWER THE PROTECTIVE IMPACT OF EICOSAPENTAENOIC ACID ON LONG-TERM MACE IN THOSE WITH AND WITHOUT ANGIOGRAPHIC CAD. Journal of the American College of Cardiology. 77(18). 1453–1453. 3 indexed citations

Schulz, Angela, Mohit Jain, Thomas Butt, et al.. (2020). The Challenges of Living with and Caring for a Child or Children Affected by Neuronal Ceroid Lipofuscinosis Type 2 Disease: In-Depth Family Surveys in the United Kingdom and Germany. SHILAP Revista de lepidopterología. 8. 6 indexed citations

Le, Viet T., Kirk U. Knowlton, Raymond O. McCubrey, et al.. (2019). Abstract 11700: Higher Plasma EPA, EPA/AA and DHA Levels Are Associated With Lower Incident MACE Both in Those With and Without Angiographic CAD. Circulation. 1 indexed citations

10.

Roberts, Charlotte, et al.. (2017). Multi-stakeholder engagement leading to access to treatment for MPS IVA (Morquio syndrome type A), a model for the ultra rare disease community. Molecular Genetics and Metabolism. 120(1-2). S115–S115. 3 indexed citations

11.

Jain, Mohit, et al.. (2015). A novel formulation of veggies with potent anti-migraine activity. International Journal of Computational Biology and Drug Design. 8(1). 54–54. 10 indexed citations

12.

Leadley, Regina, Shona Lang, Kate Misso, et al.. (2014). A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet Journal of Rare Diseases. 9(1). 173–173. 66 indexed citations

13.

Hendriksz, Christian J., Christine Lavery, Mahmut Çöker, et al.. (2014). Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey. Orphanet Journal of Rare Diseases. 9(1). 32–32. 77 indexed citations

14.

Hendriksz, Christian J., et al.. (2014). The Burden Endured by Caregivers of Patients With Morquio A Syndrome. SHILAP Revista de lepidopterología. 2. 4077866247–4077866247. 11 indexed citations

15.

Hendriksz, Christian J., et al.. (2014). Burden of disease suffered by patients with Morquio syndrome type A: results from a patient-reported outcomes survey. Molecular Genetics and Metabolism. 111(2). S53–S54. 1 indexed citations

16.

Jain, Mohit, et al.. (2013). Serial Evaluation of Microcirculatory Dysfunction in Patients With Takotsubo Cardiomyopathy by Myocardial Contrast Echocardiography. Clinical Cardiology. 36(9). 531–534. 20 indexed citations

17.

Wackers, Frans J. Th. & Mohit Jain. (2012). Response to letter. Journal of Nuclear Cardiology. 19(3). 632–632. 1 indexed citations

18.

Jain, Mohit, et al.. (2011). 85% of maximal age-predicted heart rate is not a valid endpoint for exercise treadmill testing. Journal of Nuclear Cardiology. 18(6). 1026–1035. 30 indexed citations

19.

Jain, Mohit, et al.. (2009). Human tail with spina bifida. British Journal of Neurosurgery. 23(6). 634–635. 7 indexed citations

20.

Jain, Mohit, et al.. (2007). Narrowing in on a Diagnosis. The American Journal of Medicine. 120(9). 781–782. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact